These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 15996210)

  • 1. Clinical and molecular characteristics of hereditary non-polyposis colorectal cancer families in Southeast Asia.
    Lee SC; Guo JY; Lim R; Soo R; Koay E; Salto-Tellez M; Leong A; Goh BC
    Clin Genet; 2005 Aug; 68(2):137-45. PubMed ID: 15996210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
    Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R
    N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.
    Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C
    Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
    Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
    J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population.
    Lin KM; Shashidharan M; Ternent CA; Thorson AG; Blatchford GJ; Christensen MA; Lanspa SJ; Lemon SJ; Watson P; Lynch HT
    Dis Colon Rectum; 1998 Apr; 41(4):428-33. PubMed ID: 9559626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain.
    Caldes T; Godino J; de la Hoya M; Garcia Carbonero I; Perez Segura P; Eng C; Benito M; Diaz-Rubio E
    Int J Cancer; 2002 Apr; 98(5):774-9. PubMed ID: 11920650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
    Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
    Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.
    Bapat BV; Madlensky L; Temple LK; Hiruki T; Redston M; Baron DL; Xia L; Marcus VA; Soravia C; Mitri A; Shen W; Gryfe R; Berk T; Chodirker BN; Cohen Z; Gallinger S
    Hum Genet; 1999 Feb; 104(2):167-76. PubMed ID: 10190329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
    Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG
    J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing for hereditary nonpolyposis colorectal cancer.
    Hoedema R; Monroe T; Bos C; Palmer S; Kim D; Marvin M; Luchtefeld M
    Am Surg; 2003 May; 69(5):387-91; discussion 391-2. PubMed ID: 12769209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary non-polyposis colorectal cancer (HNPCC): phenotype-genotype correlation between patients with and without identified mutation.
    Bisgaard ML; Jäger AC; Myrhøj T; Bernstein I; Nielsen FC
    Hum Mutat; 2002 Jul; 20(1):20-7. PubMed ID: 12112654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer.
    Mangold E; Pagenstecher C; Friedl W; Mathiak M; Buettner R; Engel C; Loeffler M; Holinski-Feder E; Müller-Koch Y; Keller G; Schackert HK; Krüger S; Goecke T; Moeslein G; Kloor M; Gebert J; Kunstmann E; Schulmann K; Rüschoff J; Propping P
    Int J Cancer; 2005 Sep; 116(5):692-702. PubMed ID: 15849733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
    Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
    Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
    Piñol V; Castells A; Andreu M; Castellví-Bel S; Alenda C; Llor X; Xicola RM; Rodríguez-Moranta F; Payá A; Jover R; Bessa X;
    JAMA; 2005 Apr; 293(16):1986-94. PubMed ID: 15855432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven novel MLH1 and MSH2 germline mutations in hereditary nonpolyposis colorectal cancer.
    Krüger S; Plaschke J; Pistorius S; Jeske B; Haas S; Krämer H; Hinterseher I; Bier A; Kreuz FR; Theissig F; Saeger HD; Schackert HK
    Hum Mutat; 2002 Jan; 19(1):82. PubMed ID: 11754112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten novel MSH2 and MLH1 germline mutations in families with HNPCC.
    Krüger S; Bier A; Plaschke J; Höhl R; Aust DE; Kreuz FR; Pistorius SR; Saeger HD; Rothhammer V; Al-Taie O; Schackert HK
    Hum Mutat; 2004 Oct; 24(4):351-2. PubMed ID: 15365996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features and hMSH2/hMLH1 germline mutation screening of Chinese hereditary nonpolyposis colorectal cancer patients].
    Liu SR; Wang ZJ; Zhao B; Wan YL; Huang YT
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):714-7. PubMed ID: 15200905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.